# Chemoenzymatic synthesis and identification of medium- and long-chain triacylglycerol congeners

**Authors:** Jaehyeon Park, Juno Lee, Jihoon Kim, Pahn-Shick Chang

PMC · DOI: 10.1007/s10068-025-02006-7 · Food Science and Biotechnology · 2025-10-24

## TL;DR

This paper describes a new method to synthesize specific types of triacylglycerols with defined fatty acid structures for use in functional foods.

## Contribution

A chemoenzymatic strategy was developed to synthesize and identify specific MLCT congeners with high purity and structural confirmation.

## Key findings

- Four MLCT congeners (CCL, CLC, LLC, LCL) were synthesized with yields of 52–84%.
- Structural integrity was confirmed using HPLC–ESI–MS and 13C NMR spectroscopy.
- Asymmetric and symmetric TAGs showed distinct NMR signals confirming molecular symmetry.

## Abstract

Medium- and long-chain triacylglycerols (MLCTs) offer rapid energy release and essential nutritional benefits, making them valuable in functional foods. In this study, MLCTs containing caprylic acid (C8:0; C) and linoleic acid (C18:2; L) were synthesized via a chemoenzymatic strategy combining lipase-catalyzed reactions and Steglich esterification. Four distinct MLCT congeners—CCL, CLC, LLC, and LCL—were obtained with yields of 52–67% (asymmetrical) and 71–84% (symmetrical), and purified using preparative HPLC (> 98%). The resulting compounds were structurally characterized by HPLC–ESI–MS and 13C NMR spectroscopy. HPLC–ESI–MS confirmed the expected mass-to-charge values for the [M + NH₄]⁺ adducts: 624.6 for CCL/CLC and 760.6 for LLC/LCL. 13C NMR analysis verified molecular symmetry; asymmetric TAGs showed three carbonyl signals (e.g., 173.30, 173.26, 172.88 ppm for CCL), while symmetric forms showed two signals. These results confirm the successful synthesis and structural integrity of MLCTs with defined fatty acid positioning for functional lipid applications.

## Linked entities

- **Chemicals:** caprylic acid (PubChem CID 379), linoleic acid (PubChem CID 5280450)

## Full-text entities

- **Genes:** CRYGEP (crystallin gamma E, pseudogene) [NCBI Gene 200575] {aka CCL, CRYG5, CRYGEP1, D2S1472, G2}, CLC (Charcot-Leyden crystal galectin) [NCBI Gene 1178] {aka GAL10, Gal-10, LGALS10, LGALS10A, LPPL_HUMAN}
- **Chemicals:** lipid (MESH:D008055), fatty acid (MESH:D005227), caprylic acid (MESH:C031492), linoleic acid (MESH:D019787), 13C (MESH:C000615229), MLCTs (-)
- **Cell lines:** LLC — Mus musculus (Mouse), Malignant tumors of the mouse pulmonary system, Cancer cell line (CVCL_5653)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12589742/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12589742/full.md

---
Source: https://tomesphere.com/paper/PMC12589742